Volume 27, Number 10—October 2021
Synopsis
Characteristics, Comorbidities, and Data Gaps for Coronavirus Disease Deaths, Tennessee, USA
Table 1
Characteristics of coronavirus disease patients in Tennessee, USA, March 15–August 15, 2020
Characteristic | Living, n = 128,228 | Deceased, n = 1,812 |
---|---|---|
Race and ethnicity, no. (%) | ||
White, non-Hispanic | 56,271 (43.9) | 1,093 (60.3) |
Black, non-Hispanic | 26,697 (20.8) | 540 (29.8) |
Hispanic (all races) | 21,390 (16.7) | 126 (7.0) |
All other races | 8,155 (6.4) | 49 (2.7) |
Unknown |
15,715 (12.3) |
4 (0.2) |
Sex, no. (%) | ||
F | 64,966 (50.7) | 789 (43.5) |
M | 62,100 (48.4) | 1,023 (56.5) |
Unknown |
1,162 (0.9) |
0 |
Age group, y, no. (%) | ||
0–20 | 21,703 (16.9) | 4 (0.2) |
21–64 | 93,486 (72.9) | 451 (24.9) |
65−80 | 10,080 (7.9) | 706 (39.0) |
>81 | 2,820 (2.2) | 651 (35.9) |
Unknown |
139 (0.1) |
0 |
Age group, y, has any comorbidity, no. (%)* | ||
21–64† | 20,844 (22.3) | 252 (55.9) |
65–80 | 5,043 (50.0) | 467 (66.2) |
>81 | 1441 (51.1) | 454(69.7) |
All age groups |
28,925 (22.6) |
1,174 (64.8) |
Incomplete comorbidity data, no. (%)‡ |
38,949 (30.4) |
369 (20.3) |
Mean (SD) days to hospitalization§ | 3.9 (5.4) | 3.2 (5.8) |
Mean (SD) days for obtaining specimen | 1.8 (3.7) | 1.8 (4.1) |
*Includes persons who have incomplete comorbidity; data counted as having no comorbidity. †Cell percent is the percentage within that age group (i.e., for living case-patients 21–64 years of age, the percentage is 20,844/94,486). ‡Incomplete comorbidity data were defined as any chart without a single recorded response for any preexisting condition or comorbidity. §Days to hospitalization for living patients are only calculated for case-patients hospitalized because of coronavirus disease (n = 5,379).
Page created: July 06, 2021
Page updated: September 19, 2021
Page reviewed: September 19, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.